52
Participants
Start Date
December 18, 2018
Primary Completion Date
October 19, 2021
Study Completion Date
July 18, 2022
⁸⁹Zr-Df-IAB22M2C
⁸⁹Zr-Df-IAB22M2C CD8 T cell tracer for Positron Emission Tomography (PET)
Memorial Sloan Kettering Cancer Center, New York
University of Pennsylvania, Perelman School of Medicine, Philadelphia
University of Alabama-Birmingham Hospital, Birmingham
Karmanos Cancer Institute, Detroit
University of Iowa Hospitals and Clinics, Iowa City
Washington University School of Medicine, St Louis
CARTI Cancer Center, Little Rock
Keck Hospital of USC, Los Angeles
LAC + USC Medical Center, Los Angeles
USC/Norris Comprehensive Cancer Center, Los Angeles
John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica
City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte
Hoag Memorial Hospital Presbyterian, Newport Beach
Seattle Cancer Care Alliance/ University of Washington, Seattle
Dana-Farber Cancer Institute (DFCI), Boston
Lead Sponsor
ImaginAb, Inc.
INDUSTRY